Global Immunosuppressants Market Report 2021 - Opportunities And Strategies, Market Forecast And Trends
13 Dec, 2021
Global Immunosuppressants Market Size And Drivers:
The global immunosuppressants market is expected to grow from $15.04 billion in 2020 to $16.50 billion in 2021 at a compound annual growth rate (CAGR) of 9.7%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The immunosuppressant market is expected to reach $25.33 billion in 2025 at a CAGR of 11%. The surge in organ transplant procedures such as kidney transplant and liver transplant due to the rise in incidences of organ failure is the major factor driving the immunosuppressant market growth.
Request For A Sample For The Global Immunosuppressants Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3467&type=smp
Trends In The Global Immunosuppressants Market
The phenotypic personalized medicine or PPM or a hybrid of artificial intelligence and physician intervention is a new approach to overcome the issues with immunosuppressants. For instance, Tacrolimus is the most widely used immunosuppressant for patients who are undergoing organ transplantation. When the patient is in the hospital, Tacrolimus immunosuppressant levels must be checked regularly and changed frequently. PPM approach that is based on a computational platform is used to overcome this concern. The inputs from the computational platform-based PPM approach includes the past response of the patient to the dose of the drug and other drugs that are being taken, and current data on liver and kidney. Using PPM, the physician can identify the optimal drug and dose combination from various possibilities. Therefore, it is believed that artificial intelligence is leading the way to not only more personalized and effective drug dosing but also enhancing physicians’ decision-making capabilities by providing clinical data rather than predicted responses.
Global Immunosuppressants Market Segments:
The global immunosuppressant market is further segmented –
By Drug Class: Corticosteroids, Monoclonal Antibodies (MAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents, Others
By Indication: Organ Transplantation, Autoimmune Disorders, Non-Autoimmune Inflammatory Diseases
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Geography: The global immunosuppressants market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Report For The Global Immunosuppressants Market At:
https://www.thebusinessresearchcompany.com/report/immunosuppressants-global-market-report-2020-30-covid-19-growth-and-changeImmunosuppressants Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides immunosuppressants market overviews, analyzes and forecasts market size and growth for the global immunosuppressants market, immunosuppressants market share, immunosuppressants market players, immunosuppressants market segments and geographies, immunosuppressants market’s leading competitors’ revenues, profiles and market shares. The immunosuppressants market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.